T2 Biosystems, Inc. (TTOO): Price and Financial Metrics


T2 Biosystems, Inc. (TTOO): $1.04

-0.03 (-2.80%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TTOO POWR Grades


  • Value is the dimension where TTOO ranks best; there it ranks ahead of 52.88% of US stocks.
  • The strongest trend for TTOO is in Momentum, which has been heading down over the past 47 weeks.
  • TTOO ranks lowest in Stability; there it ranks in the 4th percentile.

TTOO Stock Summary

  • Revenue growth over the past 12 months for T2 Biosystems Inc comes in at 171.09%, a number that bests 95.85% of the US stocks we're tracking.
  • In terms of volatility of its share price, TTOO is more volatile than 96.02% of stocks we're observing.
  • T2 Biosystems Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -32.15%, greater than the shareholder yield of merely 8.17% of stocks in our set.
  • Stocks that are quantitatively similar to TTOO, based on their financial statements, market capitalization, and price volatility, are AAOI, GTHX, EPZM, FORM, and ACAD.
  • TTOO's SEC filings can be seen here. And to visit T2 Biosystems Inc's official web site, go to www.t2biosystems.com.

TTOO Valuation Summary

  • In comparison to the median Healthcare stock, TTOO's EV/EBIT ratio is 115.36% lower, now standing at -4.5.
  • TTOO's price/sales ratio has moved down 1762 over the prior 86 months.
  • Over the past 86 months, TTOO's EV/EBIT ratio has gone up 5.1.

Below are key valuation metrics over time for TTOO.

Stock Date P/S P/B P/E EV/EBIT
TTOO 2021-08-31 5.8 17.2 -3.5 -4.5
TTOO 2021-08-30 5.9 17.3 -3.5 -4.6
TTOO 2021-08-27 5.9 17.5 -3.6 -4.6
TTOO 2021-08-26 5.8 17.3 -3.5 -4.6
TTOO 2021-08-25 5.9 17.5 -3.6 -4.6
TTOO 2021-08-24 5.8 17.2 -3.5 -4.5

TTOO Growth Metrics

  • Its 5 year cash and equivalents growth rate is now at -9.01%.
  • Its 3 year net income to common stockholders growth rate is now at -11%.
  • Its 2 year price growth rate is now at -90.98%.
Over the past 52 months, TTOO's revenue has gone up $22,759,000.

The table below shows TTOO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 26.683 -34.289 -44.299
2021-03-31 22.541 -37.183 -42.509
2020-12-31 18.13 -43.215 -46.798
2020-09-30 13.411 -44.584 -50.93
2020-06-30 9.843 -51.885 -53.846
2020-03-31 9.095 -47.234 -58.808

TTOO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TTOO has a Quality Grade of D, ranking ahead of 18.14% of graded US stocks.
  • TTOO's asset turnover comes in at 0.349 -- ranking 124th of 182 Medical Equipment stocks.
  • DYNT, BIOL, and ICAD are the stocks whose asset turnover ratios are most correlated with TTOO.

The table below shows TTOO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.349 0.066 -0.396
2021-03-31 0.321 0.006 -0.405
2020-12-31 0.277 -0.174 -0.620
2020-09-30 0.254 -0.298 -1.132
2020-06-30 0.235 -0.476 -2.605
2020-03-31 0.228 -0.874 -16.240

TTOO Price Target

For more insight on analysts targets of TTOO, see our TTOO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.20 Average Broker Recommendation 1.3 (Strong Buy)

TTOO Stock Price Chart Interactive Chart >

Price chart for TTOO

TTOO Price/Volume Stats

Current price $1.04 52-week high $3.79
Prev. close $1.07 52-week low $0.85
Day low $1.01 Volume 4,163,900
Day high $1.09 Avg. volume 7,249,314
50-day MA $1.01 Dividend yield N/A
200-day MA $1.45 Market Cap 172.48M

T2 Biosystems, Inc. (TTOO) Company Bio


T2 Biosystems develops diagnostic products and product candidates for the detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. The company was founded in 2006 and is based in Lexington, Massachusetts.


TTOO Latest News Stream


Event/Time News Detail
Loading, please wait...

TTOO Latest Social Stream


Loading social stream, please wait...

View Full TTOO Social Stream

Latest TTOO News From Around the Web

Below are the latest news stories about T2 Biosystems Inc that investors may wish to consider to help them evaluate TTOO as an investment opportunity.

Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?

Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.

Yahoo | September 13, 2021

TTOO Stock: The Huge Covid-19 News Lifting T2 Biosystems Today

T2 Biosystems has announced a breakthrough in Covid-19 variant testing.

Samuel O'Brient on InvestorPlace | September 10, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're back at it again with one last day of trading this week and we're kicking it off with Friday's biggest pre-market stock movers.

William White on InvestorPlace | September 10, 2021

20 Stocks Moving in Friday's Pre-Market Session

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2 Biosystems, Inc. (NASDAQ: TTOO) rose 25.8% to $1.09 in pre-market trading after the company announced its T2SARS-CoV-2 panel proved capable of detecting the Mu B.1.621 and Iota B.1.526 variants of the SARS-CoV-2 virus. Affirm Holdings, Inc. (NASDAQ: AFRM) rose 23.5% to $113.73 in pre-market trading after the company reported b

Yahoo | September 10, 2021

T2 Biosystems' Stock Jumps As Its COVID-19 Molecular Test Can Detect Mu, Iota Variants

T2 Biosystems Inc (NASDAQ: TTOO) announced that its T2SARS-CoV-2 Panel is capable of detecting the Mu (B.1.621) and Iota (B.1.526) variants, which were recently confirmed to be present in the U.S. Also Read: T2 Biosystems Q2 Earnings Edges Wall Street Estimates On Higher Test Panels Volumes, Expects Lower COVID-19 Test Sales In FY21. The T2SARS-CoV-2 Panel, which has demonstrated clinical sensitivity of 95% and specificity of 100%, provides results in under two hours utilizing an upper respirato

Yahoo | September 10, 2021

Read More 'TTOO' Stories Here

TTOO Price Returns

1-mo 17.42%
3-mo -19.38%
6-mo -43.48%
1-year -18.11%
3-year -83.41%
5-year -84.17%
YTD -16.13%
2020 5.98%
2019 -61.13%
2018 -26.94%
2017 -21.67%
2016 -51.92%

Continue Researching TTOO

Want to see what other sources are saying about T2 Biosystems Inc's financials and stock price? Try the links below:

T2 Biosystems Inc (TTOO) Stock Price | Nasdaq
T2 Biosystems Inc (TTOO) Stock Quote, History and News - Yahoo Finance
T2 Biosystems Inc (TTOO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8376 seconds.